511 related articles for article (PubMed ID: 16417634)
1. Proapoptotic activity of Ukrain is based on Chelidonium majus L. alkaloids and mediated via a mitochondrial death pathway.
Habermehl D; Kammerer B; Handrick R; Eldh T; Gruber C; Cordes N; Daniel PT; Plasswilm L; Bamberg M; Belka C; Jendrossek V
BMC Cancer; 2006 Jan; 6():14. PubMed ID: 16417634
[TBL] [Abstract][Full Text] [Related]
2. Ukrain, an alkaloid thiophosphoric acid derivative of Chelidonium majus L. protects human fibroblasts but not human tumour cells in vitro against ionizing radiation.
Cordes N; Plasswilm L; Bamberg M; Rodemann HP
Int J Radiat Biol; 2002 Jan; 78(1):17-27. PubMed ID: 11747550
[TBL] [Abstract][Full Text] [Related]
3. In-vitro toxicity of Ukrain against human Ewing tumor cell lines.
Lanvers-Kaminsky C; Nolting DM; Köster J; Schröder A; Sandkötter J; Boos J
Anticancer Drugs; 2006 Oct; 17(9):1025-30. PubMed ID: 17001175
[TBL] [Abstract][Full Text] [Related]
4. Bcl-2 overexpression protects human keratinocyte cells from Ukrain-induced apoptosis but not from G2/M arrest.
Roublevskaia IN; Haake AR; Polevoda BV
Drugs Exp Clin Res; 2000; 26(5-6):149-56. PubMed ID: 11345021
[TBL] [Abstract][Full Text] [Related]
5. Apoptogenic activity of two benzophenanthridine alkaloids from Chelidonium majus L. does not correlate with their DNA damaging effects.
Philchenkov A; Kaminskyy V; Zavelevich M; Stoika R
Toxicol In Vitro; 2008 Mar; 22(2):287-95. PubMed ID: 18023322
[TBL] [Abstract][Full Text] [Related]
6. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
Liepins A; Nowicky JW
Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
[TBL] [Abstract][Full Text] [Related]
7. [The inhibition enzymatic hydrolysis of acetylthiocholine by acetylcholinesterase using principal alkaloids isolated from celandine and macleya and their derivatives].
Kuznetsova LP; Nikol'skaia EB; Sochilina EE; Faddeeva MD
Tsitologiia; 2001; 43(11):1046-50. PubMed ID: 11840780
[TBL] [Abstract][Full Text] [Related]
8. A decisive role of mitochondria in defining rate and intensity of apoptosis induction by different alkaloids.
Kaminskyy V; Kulachkovskyy O; Stoika R
Toxicol Lett; 2008 Apr; 177(3):168-81. PubMed ID: 18325696
[TBL] [Abstract][Full Text] [Related]
9. Induction of bimodal programmed cell death in malignant cells by the derivative Ukrain (NSC-631570).
Liepins A; Nowicky JW; Bustamante JO; Lam E
Drugs Exp Clin Res; 1996; 22(3-5):73-9. PubMed ID: 8899308
[TBL] [Abstract][Full Text] [Related]
10. Induced apoptosis in human prostate cancer cell line LNCaP by Ukrain.
Roublevskaia IN; Haake AR; Ludlow JW; Polevoda BV
Drugs Exp Clin Res; 2000; 26(5-6):141-7. PubMed ID: 11345020
[TBL] [Abstract][Full Text] [Related]
11. Chemical analyses of Ukrain, a semi-synthetic Chelidonium majus alkaloid derivative, fail to confirm its trimeric structure.
Panzer A; Joubert AM; Eloff JN; Albrecht CF; Erasmus E; Seegers JC
Cancer Lett; 2000 Nov; 160(2):237-41. PubMed ID: 11053654
[TBL] [Abstract][Full Text] [Related]
12. [Inhibition of liver mitochondrial monoamine oxidase activity by alkaloids isolated from Chelidonium and Macleaya and by their derivative drugs].
Iagodina OV; Nikol'skaia EB; Faddeeva MD
Tsitologiia; 2003; 45(10):1032-7. PubMed ID: 14989176
[TBL] [Abstract][Full Text] [Related]
13. Apoptotic response of uveal melanoma cells upon treatment with chelidonine, sanguinarine and chelerythrine.
Kemény-Beke A; Aradi J; Damjanovich J; Beck Z; Facskó A; Berta A; Bodnár A
Cancer Lett; 2006 Jun; 237(1):67-75. PubMed ID: 16019128
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo investigations on the antitumour activity of Chelidonium majus.
Capistrano I R; Wouters A; Lardon F; Gravekamp C; Apers S; Pieters L
Phytomedicine; 2015 Dec; 22(14):1279-87. PubMed ID: 26626193
[TBL] [Abstract][Full Text] [Related]
15. Ukrain modulates glial fibrillary acidic protein, but not connexin 43 expression, and induces apoptosis in human cultured glioblastoma cells.
Gagliano N; Moscheni C; Torri C; Donetti E; Magnani I; Costa F; Nowicky W; Gioia M
Anticancer Drugs; 2007 Jul; 18(6):669-76. PubMed ID: 17762395
[TBL] [Abstract][Full Text] [Related]
16. Ukrain (NSC-631570) in experimental and clinical studies: a review.
Jagiello-Wójtowicz E; Kleinrok Z; Urbanska EM
Drugs Exp Clin Res; 1998; 24(5-6):213-9. PubMed ID: 10190077
[TBL] [Abstract][Full Text] [Related]
17. Protoberberine compounds extracted from Chelidonium majus L. as novel natural photosensitizers for cancer therapy.
Warowicka A; Popenda Ł; Bartkowiak G; Musidlak O; Litowczenko-Cybulska J; Kuźma D; Nawrot R; Jurga S; Goździcka-Józefiak A
Phytomedicine; 2019 Nov; 64():152919. PubMed ID: 31465980
[TBL] [Abstract][Full Text] [Related]
18. In vitro effects of Chelidonium majus L. alkaloid thiophosphoric acid conjugates (Ukrain) on the phenotype of normal human lymphocytes.
Slesak B; Nowicky JW; Harłozinska A
Drugs Exp Clin Res; 1992; 18 Suppl():17-21. PubMed ID: 1305038
[TBL] [Abstract][Full Text] [Related]
19. Role of death receptor and mitochondrial pathways in conventional chemotherapy drug induction of apoptosis.
Wang P; Song JH; Song DK; Zhang J; Hao C
Cell Signal; 2006 Sep; 18(9):1528-35. PubMed ID: 16442262
[TBL] [Abstract][Full Text] [Related]
20. Comparative cytotoxicity of chelidonine and homochelidonine, the dimethoxy analogues isolated from Chelidonium majus L. (Papaveraceae), against human leukemic and lung carcinoma cells.
Havelek R; Seifrtova M; Kralovec K; Krocova E; Tejkalova V; Novotny I; Cahlikova L; Safratova M; Opletal L; Bilkova Z; Vavrova J; Rezacova M
Phytomedicine; 2016 Mar; 23(3):253-66. PubMed ID: 26969379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
